midazolam,sotorasib
cipla,amgen
['amg 510', 'nct03600883', 'solid tumor']
 a phase i/ ii clinical trial study nct03600883 evaluates the safety and efficiency of amg 510 in adult patients with kras g12c mutations in advanced solid tumors.